Heather A. HALEM,Michael DeWitt CULLER,Andrew A. BUTLER
申请号：
US15801432
公开号：
US20180303899A1
申请日:
2017.11.02
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to peptide ligands of the melanocortin receptors, in particular the melancortin-4 receptor, and as such, are useful in the treatment of disorders responsive to the activation of this receptor, such as insulin resistance.
